Metabolic alkalosis
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]
Synonyms and keywords:
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]
Overview
The normal physiological pH of blood is 7.35 to 7.45. An increase above this range is known to be Alkalosis. Metabolic Alkalosis is defined as a disease state where blood pH is more than 7.45 due to secondary metabolic processes.
Historical Perspective
Alkalosis is defined as elevation of physiologic blood pH above 7.45. Metabolic alkalosis is caused by metabolic imbalance causing alkalosis by trapping Bicarbonate ions or loss of hydrogen in body. The discovery of electrochemistry of gas and electricity was first explored in 17th and 18th centuries . Later in late 1880s definition of acid was first developed and modified by numerous scientists from 1880s to 1950s until the epidemic era of Polio. Stewart combined all the ideas from pre-1950 and proposed a way of studying acid-base balance in clinical settings.
Classification
Metabolic Alkalosis can be classified according to pathophysiology, etiology and chloride responsiveness or urinary chloride concentration.
Pathophysiology
The primary pH buffers in maintaining chemical equilibrium of physiological Blood pH are alkaline Bicarbonate ions(HCO3) and acidic carbon dioxide(CO2). When there is increase amount of Bicarbonate(HCO3) in body or decrease amount of carbon dioxide or loss of hydrogen ions it causes alkalosis. Metabolic alkalosis occurs due to trapping of Bicarbonate ions (HCO3) or loss of hydrogen ions in body due to some metabolic causes for example- gastrointestinal loss of hydrogen ions, intracellular shifting of hydrogen ions, renal hydrogen loss, increased bicarbonate ions in extracellular compartment, diuretic induced alkalosis or contraction alkalosis. Patient with normal renal physiology will compensate this increase amount of bicarbonate through excretion. But impaired renal function secondary to chloride depletion, hypokalemia, hyperaldosteronism, reduced glomerular function rate, reduced effective arterial blood volume (EABV)) in heart failure or cirrhosis will lead to metabolic alkalosis. When the physiologic blood pH is above 7.45, it triggers respiratory center to cause hypoventilation, thus decreased PCO2 leading to compensatory respiratory acidosis. The PCO2 elevates from 0.5 to 0.7 mmHg per 1.0 millimole elevation in plasma bicarbonate concentration. In severe Metabolic alkalosis PCO2 can reach 60 mmHg. The mortality rate with metabolic alkalosis is 45% with arterial blood pH 7.55 to 80% with arterial blood pH of 7.65. Treatment is usually supportive based on cause of the disease.
Causes
Causes of Metabolic Alkalosis are Vomiting, Diarrhea, Diuretics, Cystic Fibrosis, Primary Hyperaldosteronism, Secondary hyperaldosteronism, laxative use, CKD, elactrolyte and nutritional imbalances, Milk-alkali syndrome, Blood transfusion, Genetic diseases for instances Bartter, Liddle, Gitelman syndrome etc. Among them, life threatening causes are loss of gastric acid, excessive use of loop and thiazide diuretics.
Differentiating Xyz from Other Diseases
Metabolic alkalosis might be consequence of several conditions such as exogenous HCO3− loads, medications and poisoning, gastrointestinal, renal, endocrine, and systemic diseases.
Epidemiology and Demographics
Metabolic Alkalosis has the highest incidence and prevalence rate among the other acid base disorder in hospitalized patient. Limited data are found on its predilection to race, age, gender, region.
Risk Factors
Common risk factors in the development of Metabolic Alkalosis include Vomiting, Milk-alkali syndrome, Severe hypokalemia, Primary hyperaldosterinism, Cushing syndrome, Diuretics use and genetic disease for instances- Bartter and gitelman Disease.
Screening
There is insufficient evidence to recommend routine screening for Metabolic alkalosis.
Natural History, Complications, and Prognosis
Common complications of Metabolic alkalosis include hypokalemia, hypomagnesaemia, hypophosphatemia, coronary arterial blood flow reduction, arrhythmia, anaerobic glycolysis, reduced ventilation leading to low arterial oxygen saturation, increased CO2, decreased blood flow to cerebral arteries leading to altered mental status, lethargy, tetany, delirium, seizure.
Diagnosis
Diagnostic Study of Choice
Arterial Blood Gas Analysis(ABG) is gold standard for diagnosis of Metabolic Alkalosis. Other laboratory tests, for instance Basic metabolic panel, serum aldosterone, serum renin, Urine analysis, urine pH, Urine chloride and sodium, Chest X-ray, Abdominal USG/CT are done to rule out the causes of metabolic alkalosis.
History and Symptoms
The hallmark of Metabolic Alkalosis is elevated HCO3 ion in serum primarily. A positive history of cystic fibrosis, Congenital Adrenal Hyperplasia, CHF, Uncontrolled HTN, Excess Antacid consumption, Calcium over supplementation, Penicillin use, Recent diuretics use, Vomiting, Diarrhea, Licorice consumption, Massive Blood transfusion are suggestive of Metabolic Alkalosis. The most common symptoms of Metabolic Alkalosis include nausea, vomiting, diarrhea, irritability, restlessness. Common symptoms of metabolic alkalosis include muscle cramp, tingling, tremor, slow respiration. Less common symptoms of metabolic alkalosis include loss of consciousness, altered mental status etc.
Physical Examination
Patients suffering from Metabolic alkalosis usually appear restless, irritable. Patients with metabolic alkalosis is usually remarkable for tachycardia/dysrhythmia, hypoxemia, Hypoxemia, Compensatory hypoventilation, Muscle cramps, Tremor, tingling and numbness in extremities, Weakness on clinical examination.
Laboratory Findings
Laboratory findings consistent with the diagnosis of Metabolic Alkalosis include ABG (pH >7.45, HCO3 >26 mEq/L, PCO2 compensates for increased HCO3 by decreasing.), high or low Serum aldosterone/Serum renin, and Urine analysis with Urine pH and high or low Urine chloride and sodium.
Electrocardiogram
An ECG may be helpful in the diagnosis of Hypokalemia, an etiology of metabolic alkalosis. Findings on an ECG diagnostic of Hypokalemia include Depression in ST segment with decreased T wave and , prominent U wave, and prolonged PR interval with widened QRS .
X-ray
There are no x-ray findings associated with Metabolic alkalosis. However, an x-ray may be helpful in the diagnosis of etiology of metabolic alkalosis, which include Cystic Fibrosis, Heart failure, Nephroblastoma, NG Suction.
Echocardiography and Ultrasound
There are no echocardiography/ultrasound findings associated with Metabolic alkalosis. However, an echocardiography/ultrasound may be helpful in the diagnosis of etiology of Metabolic Alkalosis, which include Heart failure, Cirrhosis, Cystic fibrosis, Pyloric stenosis, Adrenal adenoma, renal cell carcinoma, Renin producing tumor, Gastrocystoplasty and nephroblastoma.
CT scan
There are no CT scan findings associated with Metabolic alkalosis. However, an echocardiography/ultrasound may be helpful in the diagnosis of etiology of Metabolic Alkalosis, which include Heart failure, Cirrhosis, Cystic fibrosis, Pyloric stenosis, Adrenal adenoma, renal cell carcinoma, Renin producin tumor, Gastrocystoplasty and nephroblastoma.
MRI
There are no MRI findings associated with Metabolic alkalosis. However, an echocardiography/ultrasound may be helpful in the diagnosis of etiology of Metabolic Alkalosis, which include Heart failure, Cirrhosis, Cystic fibrosis, Pyloric stenosis, Adrenal adenoma, renal cell carcinoma, Renin producin tumor, Gastrocystoplasty and nephroblastoma.
Other Imaging Findings
There are no other imaging findings associated with Metabolic alkalosis.
Other Diagnostic Studies
Genetic testing for identifying genes involved in the pathogenesis of Metabolic Alkalosis include CFTR, SCNN1A/SCNN1B/SCNN1G, NKCC2;, SLC12A3/CLCNKB, SLC26A3 causing Cystic Fibrosis, Liddle Syndrome, Bartter syndrome, Gitelman syndrome and Congenital Chloride Diarrhhea respectively.
Treatment
Medical Therapy
Supportive therapy for Metabolic alkalosis includes volume repletion, electrolyte repletion, removal of inducing source and after stabilizing patient treatment according to etiology. Pharmacologic medical therapy is recommended among patients with electrolyte imbalances, hypervolemia, loss of GI hydrogen.
Surgery
The mainstay of treatment for metabolic alkalosis is medical therapy. Surgery is usually reserved for patients with either pyloric stenosis), Zollinger- Ellison syndrome, Villous adenoma, Conn syndrome or adrenal adenoma/ hyperplasia /carcinoma, Reno vascular hypertension, juxtaglomerular cell(renin producing) tumor, renal cell carcinoma, hemangiopericytoma, nephroblastoma.
Primary Prevention
There are no available vaccines against Metabolic alkalosis.
Secondary Prevention
Effective measures for the secondary prevention of metabolic alkalosis include resuscitation with airway, breathing, circulation, correction of electrolyte imbalance, and removal of inciting sources.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]
Overview
Alkalosis is defined as elevation of physiologic blood pH above 7.45. Metabolic alkalosis is caused by metabolic imbalance causing alkalosis by trapping Bicarbonate ions or loss of hydrogen in body. The discovery of electrochemistry of gas and electricity was first explored in 17th and 18th centuries . Later in late 1880s definition of acid was first developed and modified by numerous scientists from 1880s to 1950s until the epidemic era of Polio. Stewart combined all the ideas from pre-1950 and proposed a way of studying acid-base balance in clinical settings.
Historical Perspective
In the beginning era of exploration of acid-base physiology, there are contribution of many scientists from 1880s to modern time. In 1880s Arrhenius defined acid for the first time as a substance which helped in increasing hydrogen ions concentration when dissolving with water. Naunyn combined definitions from Arrhenius and Faraday and came up with ideas of electrolytes determining acid-base physiology.[1] Van Slyke modified the definition of acid by Naunyn in 1920. Bronsted and Lowry defined acid as a substance donating hydrogen ion just after World War One, whereas Lewis suggested acid as acceptor of electron pair. Henderson and Hasselbalch contributed in development of Henderson-Hasselbalch equation linking pH, PCO2, HCO3 concentration in 1908 and 1916 respectively. The role of HCO3 in acid-base physiology first came up in 1950s.[2][3]
Discovery
A group of physicians from Denmark erroneously discovered metabolic alkalosis by using bicarbonate concentration in plasma during the emergence of polio epidemic in 1952.[4]
Outbreaks
The Polio epidemic triggered the development of glass electrode and detection of pH by Astrup in blood. He worked with Siggard-Anderson to build the foundation od clinical acid-base balance.[5]
Landmark Events in the Development of Treatment Strategies
From 1970 to 1980s Stewart showed detailed integration of clinical acid-base physiology and applied HCO3 centered in clinical settings.[6]
References
- ↑ RELMAN AS (October 1954). “What are acids and bases?”. Am J Med. 17 (4): 435–7. doi:10.1016/0002-9343(54)90118-7. PMID 13197407.
- ↑ Severinghaus JW (1993). “Siggaard-Andersen and the “Great Trans-Atlantic Acid-Base Debate““. Scand J Clin Lab Invest Suppl. 214: 99–104. PMID 8332859.
- ↑ Siggaard-Andersen O, Fogh-Andersen N (1995). “Base excess or buffer base (strong ion difference) as measure of a non-respiratory acid-base disturbance”. Acta Anaesthesiol Scand Suppl. 107: 123–8. doi:10.1111/j.1399-6576.1995.tb04346.x. PMID 8599264.
- ↑ Story DA (August 2004). “Bench-to-bedside review: a brief history of clinical acid-base”. Crit Care. 8 (4): 253–8. doi:10.1186/cc2861. PMC 522833. PMID 15312207.
- ↑ Severinghaus JW, Astrup PB (October 1985). “History of blood gas analysis. II. pH and acid-base balance measurements”. J Clin Monit. 1 (4): 259–77. doi:10.1007/BF02832819. PMID 3913750.
- ↑ Kellum JA (2000). “Determinants of blood pH in health and disease”. Crit Care. 4 (1): 6–14. doi:10.1186/cc644. PMC 137247. PMID 11094491.
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]
Overview
Metabolic Alkalosis can be classified according to pathophysiology, etiology and chloride responsiveness or urinary chloride concentration.
Classification
- 1.The following classification of Metabolic Alkalosis is based on Pathophysiology[1]:
| Metabolic Alkalosis | |||||||||||||||||||
| Stimulation on Collecting Duct | |||||||||||||||||||
| Primary stimulation by Mineralocorticoid Excess causing HTN: •Congenital Adrenal Hyperplasia •Cushing Syndrome •Primary aldosteronism •Renin Secreting tumors •Medications(Fluoroprednisolone, Fludrocortisone) •Liddle Syndrome •11 beta hydroxysteroid dehydrogenase deficiency | Secondary Stimulation by Chloride depletion causing normal or low blood pressure: •Vomiting •NG tube intubation •Congenital Chloridorrhea •Ileostomy •Cystic fibrosis •Diuretics •Bartter syndrome •Gitelman syndrome •Hypokalemia | ||||||||||||||||||
- 2.The classification based on etiologies are following:
- Chloride depletion or Gastrointestinal loss of hydrogen
- GI loss: Vomiting (most commonly seen in pyloric stenosis), NG suction , Zollinger-ellison syndrome, Bulimia.[2]
- Diuretics: Loop and thiazide diuretics.
- Diarrhea: Villous adenoma[3], congenital chloride diarrhea[4]
- Cystic fibrosis.[5]
- Chloride deficient infant formula.
- Gastrocystoplasty [6]
- Post hypercapneic metabolic alkalosis.
- Potassium depletion or Mineralocorticoids excess or Renal loss of hydrogen
- Dietary potassium depletion.[7]
- Primary hyperaldosteronism: Conn syndrome or adenoma, hyperplasia, carcinoma, renin or glucocorticoid responsive.
- Secondary hyperaldosteronism: Reno vascular hypertension, edema (cirrhosis, heart failure, nephrotic syndrome), juxtaglomerular cell(renin producing) tumor, renal cell carcinoma, hemangiopericytoma, nephroblastoma
- Mineralocorticoid excess due to primary decorticosterone excess (11 beta, 17 alpha hydroxylase deficiency), licorice(glycyrrhetinic acid), liddle syndrome.[8] [9]
- Bartter and Gitelman syndrome. [10]
- Laxative
- Reduced Glomerular filtration rate
- ECF volume depletion/ Volume contraction
- Hypovolemia or massive diuresis with loop diuretics.
- Miscellanous
- Hypercalcemia due to Milk-alkali syndrome or bone metastasis.
- Massive blood transfusion.
- Acetate containing colloid sollution.
- Exogenous alkali admintration.
- Combined antacid and cation exchange resin administration.
- Sodium penicillins.
References
- ↑ “Metabolic Alkalosis – Jeffrey M. Rimmer, F. John Gennari, 1987”.
- ↑ Galla JH, Gifford JD, Luke RG, Rome L (October 1991). “Adaptations to chloride-depletion alkalosis”. Am J Physiol. 261 (4 Pt 2): R771–81. doi:10.1152/ajpregu.1991.261.4.R771. PMID 1928424.
- ↑ Babior BM (October 1966). “Villous adenoma of the colon. Study of a patient with severe fluid and electrolyte disturbances”. Am J Med. 41 (4): 615–21. doi:10.1016/0002-9343(66)90223-3. PMID 5927076.
- ↑ Höglund P, Haila S, Socha J, Tomaszewski L, Saarialho-Kere U, Karjalainen-Lindsberg ML, Airola K, Holmberg C, de la Chapelle A, Kere J (November 1996). “Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea”. Nat Genet. 14 (3): 316–9. doi:10.1038/ng1196-316. PMID 8896562.
- ↑ Pedroli G, Liechti-Gallati S, Mauri S, Birrer P, Kraemer R, Foletti-Jäggi C, Bianchetti MG (1995). “Chronic metabolic alkalosis: not uncommon in young children with severe cystic fibrosis”. Am J Nephrol. 15 (3): 245–50. doi:10.1159/000168839. PMID 7618650.
- ↑ Plawker MW, Rabinowitz SS, Etwaru DJ, Glassberg KI (August 1995). “Hypergastrinemia, dysuria-hematuria and metabolic alkalosis: complications associated with gastrocystoplasty”. J Urol. 154 (2 Pt 1): 546–9. doi:10.1097/00005392-199508000-00066. PMID 7609133.
- ↑ Sabatini S (March 1996). “The cellular basis of metabolic alkalosis”. Kidney Int. 49 (3): 906–17. doi:10.1038/ki.1996.125. PMID 8648937.
- ↑ Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (January 1992). “A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension”. Nature. 355 (6357): 262–5. doi:10.1038/355262a0. PMID 1731223.
- ↑ Warnock DG (January 1998). “Liddle syndrome: an autosomal dominant form of human hypertension”. Kidney Int. 53 (1): 18–24. doi:10.1046/j.1523-1755.1998.00728.x. PMID 9452995.
- ↑ Kurtz I (October 1998). “Molecular pathogenesis of Bartter’s and Gitelman’s syndromes”. Kidney Int. 54 (4): 1396–410. doi:10.1046/j.1523-1755.1998.00124.x. PMID 9767561.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]
Overview
The normal physiological pH of blood is 7.35 to 7.45. An increase above this range is known to be Alkalosis. Metabolic Alkalosis is defined as a disease state where blood pH is more than 7.45 due to secondary metabolic processes. The primary pH buffers in maintaining chemical equilibrium of physiological Blood pH are alkaline Bicarbonate ions(HCO3) and acidic carbon dioxide(CO2). When there is increase amount of Bicarbonate(HCO3) in body or decrease amount of carbon dioxide or loss of hydrogen ions it causes alkalosis. Metabolic alkalosis occurs due to trapping of Bicarbonate ions (HCO3) or loss of hydrogen ions in body due to some metabolic causes for example- gastrointestinal loss of hydrogen ions, intracellular shifting of hydrogen ions, renal hydrogen loss, increased bicarbonate ions in extracellular compartment, diuretic induced alkalosis or contraction alkalosis. Patient with normal renal physiology will compensate this increase amount of bicarbonate through excretion. But impaired renal function secondary to chloride depletion, hypokalemia, hyperaldosteronism, reduced glomerular function rate, reduced effective arterial blood volume (EABV)) in heart failure or cirrhosis will lead to metabolic alkalosis. When the physiologic blood pH is above 7.45, it triggers respiratory center to cause hypoventilation, thus decreased PCO2 leading to compensatory respiratory acidosis. The PCO2 elavates from 0.5 to 0.7 mmHg per 1.0 millimole elevation in plasma bicarbonate concentration. In severe Metabolic alkalosis PCO2 can reach 60 mmHg. The mortality rate with metabolic alkalosis is 45% with arterial blood pH 7.55 to 80% with arterial blood pH of 7.65. Supportive Treatment is usually given according to cause of the disease.
Pathophysiology
H+ loss
Gastrointestinal loss
- [[Emesis] (most commonly seen in pyloric stenosis), NG suction , Zollinger-ellison syndrome, Bulimia.[1]
- Diuretics: Loop and thiazide diuretics.
- Diarrhea: Villous adenoma[2], congenital chloride diarrhea[3]
- Cystic fibrosis.[4]
- Chloride deficient infant formula.
- Gastrocystoplasty [5]
- Post hypercapneic metabolic alkalosis.
Renal
- Dietary potassium depletion.[6]
- Primary hyperaldosteronism: Conn syndrome or adenoma, hyperplasia, carcinoma, renin or glucocorticoid responsive.
- Secondary hyperaldosteronism: Reno vascular hypertension, edema (cirrhosis, heart failure, nephrotic syndrome), juxtaglomerular cell(renin producing) tumor, renal cell carcinoma, hemangiopericytoma, nephroblastoma
- Mineralocorticoid excess due to primary decorticosterone excess (11 beta, 17 alpha hydroxylase deficiency), licorice(glycyrrhetinic acid), liddle syndrome.[7] [8]
- Bartter and Gitelman syndrome. [9]
Elevated HCO3- level in serum
- Intake of NaCO3, citrate, baking powder, lactate and acetate.
Transport of H+ to IC space
- Occurs in hypokalemia. Decreased extracellular K+, potassium transports from the cells, and to keep electrical potential in a balanced state, Transport of H+ to IC space.
Contraction Alkalosis
- Loss of low concerntation of HCO3 mixed H2O in EC space by diuretics. HCO3 is elevated in serum..
Compensatory mechanism of Metabolic Alkalosis
- hypoventilation (respiratory compensation) elevates pH by restoring carbon dioxide (CO2) through . Carbonic acid is generated by CO2. The acidic medium is created for compensation.
- The pCO2 elevates from 0.5 to 1 per 1 u serum HCO3 elevation.
- Body can compensate up tp 55-60 mmHg of partial pressure of CO2.
- Increased secretion of HCO3– (bicarbonate) by kidney is done.
Genetics
- Genes involved in the pathogenesis of Metabolic Alkalosis include CFTR, SCNN1A/SCNN1B/SCNN1G[10], NKCC2[11] SLC12A3/CLCNKB[12] and SLC26A3 [13] causing Cystic Fibrosis, Liddle Syndrome, Bartter syndrome, Gitelman syndrome and Congenital Chloride Diarrhhea respectively.
Associated Conditions
Conditions associated with metabolic alkalosis :
- Vomiting (most commonly seen in pyloric stenosis
- NG suction
- Zollinger-ellison syndrome
- Bulimia.[1]
- Diuretics: Loop and thiazide diuretics.
- Villous adenoma[2]
- congenital chloride diarrhea[3]
- Cystic fibrosis[4]
- Chloride deficient infant formula.
- Gastrocystoplasty [5]
- Post hypercapneic metabolic alkalosis.
- Dietary potassium depletion.[6]
- Primary hyperaldosteronism: Conn syndrome or adenoma, hyperplasia, carcinoma, renin or glucocorticoid responsive.
- Secondary hyperaldosteronism: Reno vascular hypertension, edema (cirrhosis, heart failure, nephrotic syndrome), juxtaglomerular cell(renin producing) tumor, renal cell carcinoma, hemangiopericytoma, nephroblastoma
- Mineralocorticoid excess due to primary decorticosterone excess (11 beta, 17 alpha hydroxylase deficiency), licorice(glycyrrhetinic acid), liddle syndrome.[7] [8]
- Bartter and Gitelman syndrome. [9]
- Laxative
- Chronic kidney disease
- Hypovolemia or massive diuresis with loop diuretics.
- Milk-alkali syndrome or bone metastasis.
- Massive blood transfusion.
- Acetate containing colloid sollution.
- Exogenous alkali admintration.
- Combined antacid and cation exchange resin administration.
- Sodium penicillins.
Gross Pathology
- There is no specific gross pathological finding related to metabolic alkalosis. Gross characteristics are dependent on specific cause of metabolic alkalosis.
Microscopic Pathology
- There is no specific microscopic pathological finding related to metabolic alkalosis. Gross characteristics are dependent on specific cause of metabolic alkalosis.
References
- ↑ 1.0 1.1 Galla JH, Gifford JD, Luke RG, Rome L (October 1991). “Adaptations to chloride-depletion alkalosis”. Am J Physiol. 261 (4 Pt 2): R771–81. doi:10.1152/ajpregu.1991.261.4.R771. PMID 1928424.
- ↑ 2.0 2.1 Babior BM (October 1966). “Villous adenoma of the colon. Study of a patient with severe fluid and electrolyte disturbances”. Am J Med. 41 (4): 615–21. doi:10.1016/0002-9343(66)90223-3. PMID 5927076.
- ↑ 3.0 3.1 Höglund P, Haila S, Socha J, Tomaszewski L, Saarialho-Kere U, Karjalainen-Lindsberg ML, Airola K, Holmberg C, de la Chapelle A, Kere J (November 1996). “Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea”. Nat Genet. 14 (3): 316–9. doi:10.1038/ng1196-316. PMID 8896562.
- ↑ 4.0 4.1 Pedroli G, Liechti-Gallati S, Mauri S, Birrer P, Kraemer R, Foletti-Jäggi C, Bianchetti MG (1995). “Chronic metabolic alkalosis: not uncommon in young children with severe cystic fibrosis”. Am J Nephrol. 15 (3): 245–50. doi:10.1159/000168839. PMID 7618650.
- ↑ 5.0 5.1 Plawker MW, Rabinowitz SS, Etwaru DJ, Glassberg KI (August 1995). “Hypergastrinemia, dysuria-hematuria and metabolic alkalosis: complications associated with gastrocystoplasty”. J Urol. 154 (2 Pt 1): 546–9. doi:10.1097/00005392-199508000-00066. PMID 7609133.
- ↑ 6.0 6.1 Sabatini S (March 1996). “The cellular basis of metabolic alkalosis”. Kidney Int. 49 (3): 906–17. doi:10.1038/ki.1996.125. PMID 8648937.
- ↑ 7.0 7.1 Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (January 1992). “A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension”. Nature. 355 (6357): 262–5. doi:10.1038/355262a0. PMID 1731223.
- ↑ 8.0 8.1 Warnock DG (January 1998). “Liddle syndrome: an autosomal dominant form of human hypertension”. Kidney Int. 53 (1): 18–24. doi:10.1046/j.1523-1755.1998.00728.x. PMID 9452995.
- ↑ 9.0 9.1 Kurtz I (October 1998). “Molecular pathogenesis of Bartter’s and Gitelman’s syndromes”. Kidney Int. 54 (4): 1396–410. doi:10.1046/j.1523-1755.1998.00124.x. PMID 9767561.
- ↑ Tetti M, Monticone S, Burrello J, Matarazzo P, Veglio F, Pasini B, Jeunemaitre X, Mulatero P (March 2018). “Liddle Syndrome: Review of the Literature and Description of a New Case”. Int J Mol Sci. 19 (3). doi:10.3390/ijms19030812. PMC 5877673. PMID 29534496.
- ↑ Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, Sanjad SA, Lifton RP (October 1996). “Genetic heterogeneity of Bartter’s syndrome revealed by mutations in the K+ channel, ROMK”. Nat Genet. 14 (2): 152–6. doi:10.1038/ng1096-152. PMID 8841184.
- ↑ Vargas-Poussou R, Dahan K, Kahila D, Venisse A, Riveira-Munoz E, Debaix H, Grisart B, Bridoux F, Unwin R, Moulin B, Haymann JP, Vantyghem MC, Rigothier C, Dussol B, Godin M, Nivet H, Dubourg L, Tack I, Gimenez-Roqueplo AP, Houillier P, Blanchard A, Devuyst O, Jeunemaitre X (April 2011). “Spectrum of mutations in Gitelman syndrome”. J Am Soc Nephrol. 22 (4): 693–703. doi:10.1681/ASN.2010090907. PMC 3065225. PMID 21415153.
- ↑ Kamal NM, Khan HY, El-Shabrawi M, Sherief LM (May 2019). “Congenital chloride losing diarrhea: A single center experience in a highly consanguineous population”. Medicine (Baltimore). 98 (22): e15928. doi:10.1097/MD.0000000000015928. PMC 6709049 Check
|pmc=value (help). PMID 31145360. Vancouver style error: initials (help)
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]
Overview
Causes of Metabolic Alkalosis are Vomiting, Diarrhea, Diuretics, Cystic Fibrosis, Primary Hyperaldosteronism, Secondary hyperaldosteronism, laxative use, CKD, elactrolyte and nutritional imbalances, Milk-alkali syndrome, Blood transfusion, Genetic diseases for instances Bartter, Liddle, Gitelman syndrome etc. Among them, life threatening causes are loss of gastric acid, excessive use of loop and thiazide diuretics.
Causes
There are several causes of metabolic alkalosis. Life threatening causes of severe metabolic alkalosis (pH 7.55 to 7.65) may result in death (45% to 80%) or permanent disability within 24 hours if left untreated.[1]
Common Causes
- Chloride depletion or Gastrointestinal loss of hydrogen
- GI loss: Vomiting (most commonly seen in pyloric stenosis), NG suction , Zollinger-ellison syndrome, Bulimia.[2]
- Diuretics: Loop and thiazide diuretics.
- Diarrhea
- Cystic fibrosis.[3]
- Chloride deficient infant formula.
- Potassium depletion or Mineralocorticoids excess or Renal loss of hydrogen
- Dietary potassium depletion.[4]
- Primary hyperaldosteronism: Conn syndrome or adenoma, hyperplasia, carcinoma, renin or glucocorticoid responsive.
- Secondary hyperaldosteronism: Reno vascular hypertension, edema (cirrhosis, heart failure, nephrotic syndrome), juxtaglomerular cell(renin producing) tumor, renal cell carcinoma, nephroblastoma
- Mineralocorticoid excess due to primary decorticosterone excess (11 beta, 17 alpha hydroxylase deficiency), licorice(glycyrrhetinic acid) Closing
</ref>missing for<ref>tag - congenital chloride diarrhea[5]
- Bartter and Gitelman syndrome. [6]
- liddle syndrome</ref> [7]
- hemangiopericytoma
- Gastrocystoplasty [8]
- Post hypercapneic metabolic alkalosis.
Causes by Organ System
Causes in Alphabetical Order
- ↑ Tripathy S (October 2009). “Extreme metabolic alkalosis in intensive care”. Indian J Crit Care Med. 13 (4): 217–20. doi:10.4103/0972-5229.60175. PMC 2856150. PMID 20436691.
- ↑ Galla JH, Gifford JD, Luke RG, Rome L (October 1991). “Adaptations to chloride-depletion alkalosis”. Am J Physiol. 261 (4 Pt 2): R771–81. doi:10.1152/ajpregu.1991.261.4.R771. PMID 1928424.
- ↑ Pedroli G, Liechti-Gallati S, Mauri S, Birrer P, Kraemer R, Foletti-Jäggi C, Bianchetti MG (1995). “Chronic metabolic alkalosis: not uncommon in young children with severe cystic fibrosis”. Am J Nephrol. 15 (3): 245–50. doi:10.1159/000168839. PMID 7618650.
- ↑ Sabatini S (March 1996). “The cellular basis of metabolic alkalosis”. Kidney Int. 49 (3): 906–17. doi:10.1038/ki.1996.125. PMID 8648937.
- ↑ Höglund P, Haila S, Socha J, Tomaszewski L, Saarialho-Kere U, Karjalainen-Lindsberg ML, Airola K, Holmberg C, de la Chapelle A, Kere J (November 1996). “Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea”. Nat Genet. 14 (3): 316–9. doi:10.1038/ng1196-316. PMID 8896562.
- ↑ Kurtz I (October 1998). “Molecular pathogenesis of Bartter’s and Gitelman’s syndromes”. Kidney Int. 54 (4): 1396–410. doi:10.1046/j.1523-1755.1998.00124.x. PMID 9767561.
- ↑ Warnock DG (January 1998). “Liddle syndrome: an autosomal dominant form of human hypertension”. Kidney Int. 53 (1): 18–24. doi:10.1046/j.1523-1755.1998.00728.x. PMID 9452995.
- ↑ Plawker MW, Rabinowitz SS, Etwaru DJ, Glassberg KI (August 1995). “Hypergastrinemia, dysuria-hematuria and metabolic alkalosis: complications associated with gastrocystoplasty”. J Urol. 154 (2 Pt 1): 546–9. doi:10.1097/00005392-199508000-00066. PMID 7609133.
Differentiating Metabolic alkalosis from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Metabolic alkalosis might be consequence of several conditions such as exogenous HCO3− loads, medications and poisoning, gastrointestinal, renal, endocrine, and systemic diseases.
Metabolic Alkalosis
Differential diagnosis of metabolic alkalosis is as follow:
| Category | Disease | Mechanism | Clinical | Paraclinical | Gold standard diagnosis | Other findings | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Signs | Lab data | ||||||||||||||||||||||||
| ABG | Chemistry | Enzyme | Renal function | |||||||||||||||||||||||
| Hydrogen loss | Accumulation of base | Chloride depletion | Mineralocorticoid excess | Fever | Dyspnea | Edema | Toxic/ill | BP | Dehydration | HCO3− | paCO2 | O2 | Cl− | K+ | Na+ | Ca+ | Mg+ | Renin | Bun | Cr | Urine Cl− | |||||
| Exogenous HCO3− loads | Acute alkali administration[1] | − | + | − | − | − | + | − | + | ↓ | − | ↑ | ↑ | ↓ | ↓ | ↓ | ↓ | ↑ | Nl | Nl | ↑ | ↑ | Nl | Clinical manifestations |
| |
| Milk−alkali syndrome[2] | − | + | − | + | − | + | − | + | ↓ | + | ↑ | ↑ | ↓ | ↓ | ↓ | ↓ | ↑ | ↓ | ↑ | ↑ | ↑ | Nl | Clinical manifestationsk + exclusion of other causes of hypercalcemia |
| ||
| Transfusion[3] | − | + | − | − | ± | ± | − | + | ↓ | − | ↑ | ↑ | ↓ | ↓ | ↓/↑ | ↓ | ↓ | ↑ | ↑ | Nl to ↑ | Nl to ↑ | Nl | History of administration of large quantities of blood products that contain sodium citrate |
| ||
| Drugs/Medication | Chloruretic diuretics[4] | + | − | + | + | − | − | − | − | ↓ | + | ↑ | ↑ | Nl | ↓ | ↓ | ↑ | Nl | Nl | ↑ | Nl to ↑ | Nl to ↑ | ↑ | History of diuretic use | ||
| Penicillin[5] | + | − | − | − | − | − | − | − | Nl | − | ↑ | ↑ | Nl | ↓ | ↓ | ↑ | Nl | ↓ | ↑ | Nl | Nl | Nl | History of penicillin use |
| ||
| Licorice[6][7] | + | − | − | + | − | − | − | + | Nl to ↑ | − | ↑ | ↑ | Nl | ↓ | ↓ | ↑ | Nl | Nl | ↑ | Nl to ↑ | Nl to ↑ | Nl | Clinical manifestations | |||
| Laxative abuse[8] | + | − | + | − | − | − | ± | + | ↓ | + | ↑ | ↑ | Nl | ↓ | ↓ | ↑ | Nl | ↑ | ↑ | Nl to ↑ | Nl | ↓ | High level of suspicion |
| ||
| Antacids[9][10] |
|
+ | + | − | − | − | − | − | − | Nl | − | ↑ | ↑ | Nl | ↓ | ↓ | ↑ | Nl | ↑ | Nl | Nl to ↑ | Nl to ↑ | Nl | Clinical manifestations |
| |
| Category | Disease | Hydrogen loss | Accumulation of base | Chloride depletion | Mineralocorticoid excess | Fever | Dyspnea | Edema | Toxic/ill | BP | Dehydration | HCO3− | paCO2 | O2 | Cl− | K+ | Na+ | Ca+ | Mg+ | Renin | Bun | Cr | Urine Cl− | Gold standard diagnosis | Other findings | |
| Gastrointestinal origin | Vomiting[11] | + | − | + | − | ± | − | − | + | ↓ | + | ↑ | ↑ | Nl | ↓ | ↓ | ↑ | Nl | Nl | ↑ | Nl to ↑ | Nl | ↓ | Clinical manifestations |
| |
| Nasogastric tube suction[12] | + | − | + | − | − | − | − | + | ↓ | + | ↑ | ↑ | Nl | ↓ | ↓ | ↑ | Nl | Nl | ↑ | Nl to ↑ | Nl | ↓ | Clinical manifestations | |||
| Zollinger−Ellison syndrome[13] | + | − | + | − | − | − | − | + | ↓ | + | ↑ | ↑ | Nl | ↓ | ↓ | ↑ | Nl | Nl | ↑ | Nl to ↑ | Nl | ↓ | Serum gastrin concentration + secretin stimulation test |
| ||
| Bulimia nervosa[14] | + | − | + | − | − | − | ± | + | ↓ | + | ↑ | ↑ | Nl | ↓ | ↓ | ↓ | Nl | ↓ | ↑ | Nl to ↑ | Nl | ↓ | High level of suspicion |
| ||
| Congenital chloridorrhea[15] | + | − | + | − | − | − | ± | + | ↓ | + | ↑ | ↑ | Nl | ↓ | ↓ | ↓ | ↓ | ↓ | ↑ | Nl to ↑ | Nl to ↑ | Nl to ↑ | Clinical manifestations+ lab findings |
| ||
| Pyloric stenosis[16] | + | − | + | − | − | − | − | + | ↓ | + | ↑ | ↑ | Nl | ↓ | ↓ | ↓ ↑ | Nl | Nl | ↑ | Nl to ↑ | Nl | ↓ | Physical exam + imaging |
| ||
| Villous adenoma[17] | + | − | + | − | − | − | − | + | ↓ | + | ↑ | ↑ | Nl | ↓ | ↓ | ↓ | ↓ | ↓ | ↑ | Nl to ↑ | Nl | ↑ | Colonoscopy | |||
| Gastrocystoplasty[18] | − | − | + | − | − | − | + | − | ↓ | − | ↑ | ↑ | Nl | ↓ | Nl | Nl | Nl | Nl | Nl | Nl to ↑ | Nl to ↑ | Nl | History of operation | |||
| Category | Disease | Hydrogen loss | Accumulation of base | Chloride depletion | Mineralocorticoid excess | Fever | Dyspnea | Edema | Toxic/ill | BP | Dehydration | HCO3− | paCO2 | O2 | Cl− | K+ | Na+ | Ca+ | Mg+ | Renin | Bun | Cr | Urine Cl− | Gold standard diagnosis | Other findings | |
| Renal origin | Posthypercapnic state[19] | − | − | + | + | − | ± | − | − | Nl | − | ↑ | ↑↑ | ↓ | ↓ | ↓ | ↑ | Nl | Nl | ↑ | Nl | Nl | Nl | Lab findings |
| |
| Hypomagnesemia[20] | + | − | − | − | − | − | − | − | Nl | − | ↑ | ↑ | Nl | ↓ | ↓ | ↑ | Nl | Nl | ↑ | Nl | Nl | Nl | Lab findings |
| ||
| Hypokalemia[21] | + | − | − | − | − | − | − | − | Nl | − | ↑ | ↑ | Nl | ↓ | ↓ | ↑ | Nl | Nl | ↑ | Nl | Nl | Nl | Lab findings |
| ||
| Bartter’s syndrome[22] | + | − | − | + | − | − | − | − | Nl | + | ↑ | ↑ | Nl | ↓ | ↓↓ | ↓ | ↓ | Nl | ↑ | Nl to ↑ | Nl to ↑ | Nl | Genetic testing | |||
| Gitelman’s syndrome[23][24] | + | − | − | + | − | − | − | − | ↓ | + | ↑ | ↑ | Nl | ↓ | ↓↓ | ↓ | Nl | ↓ | ↑ | Nl | Nl | Nl | Genetic testing |
| ||
| Renal artery stenosis[25] | + | − | + | − | − | + | + | + | ↑ | + | ↑ | ↑ | ↓ | ↓ | ↑ | ↓ | ↑ | Nl | ↑ | ↑ | ↑ | Nl | Clinical manifestations+ imaging |
| ||
| Liddle syndrome[26] | + | − | − | + | − | − | − | − | ↑ | + | ↑ | ↑ | Nl | ↓ | ↓↓ | ↓ | Nl | ↓ | ↑ | Nl | Nl | Nl | Genetic testing |
| ||
| Renal tumors[27] | + | − | + | − | − | + | + | + | ↑ | + | ↑ | ↑ | ↓ | ↓ | ↑ | ↓ | ↑ | Nl | ↑ | ↑ | ↑ | Nl | Biopsy |
| ||
| Endocrine | Cushing’s syndrome[28] | + | − | + | − | − | − | + | − | ↑ | + | ↑ | ↑ | Nl | ↓ | ↑ | ↓ | ↑ | Nl | ↓ | ↑ | ↑ | Nl | 24−hour urinary cortisol excretion + low−dose dexamethasone suppression test | ||
| Hyperaldosteronism | Primary[29] | + | − | + | − | − | − | + | − | ↑ | + | ↑ | ↑ | Nl | ↓ | Nl to ↓ | ↓ | ↑ | Nl | ↓ | ↑ | ↑ | Nl | Lab findings |
| |
| Secondary[30] | + | − | + | − | − | + | + | + | ↑ | + | ↑ | ↑ | Nl | ↓ | ↓ | ↑ | Nl | ↓ | ↑ | ↑ | ↑ | Nl | Lab findings |
| ||
| Congenital adrenal hyperplasia | 11β−Hydroxylase deficiency[31] | − | − | − | + | − | − | + | − | ↑ | + | ↑ | ↑ | Nl | ↓ | ↓ | ↓ | ↑ | Nl | ↓ | Nl | Nl | Nl | Genetic testing |
| |
| 17α−Hydroxylase deficiency[32] | − | − | − | + | − | − | + | − | ↑ | + | ↑ | ↑ | Nl | ↓ | ↓ | ↓ | ↑ | Nl | ↓ | Nl | Nl | Nl | Genetic testing |
| ||
| Systemic | Cystic fibrosis[33] | + | − | + | − | − | + | − | + | ↓ | + | ↑ | ↑ | Nl | ↓ | ↓ | Nl | Nl | Nl | ↑ | Nl to ↑ | Nl | ↑ | Genetic testing |
| |
| Category | Disease | Hydrogen loss | Accumulation of base | Chloride depletion | Mineralocorticoid excess | Fever | Dyspnea | Edema | Toxic/ill | BP | Dehydration | HCO3− | paCO2 | O2 | Cl− | K+ | Na+ | Ca+ | Mg+ | Renin | Bun | Cr | Urine Cl− | Gold standard diagnosis | Other findings | |
References
- ↑ Máttar, João A.; Weil, Max Harry; Shubin, Herbert; Stein, Leon (1974). “Cardiac arrest in the critically III”. The American Journal of Medicine. 56 (2): 162–168. doi:10.1016/0002-9343(74)90593-2. ISSN 0002-9343.
- ↑ Abreo, Kenneth (1993). “The Milk-Alkali Syndrome”. Archives of Internal Medicine. 153 (8): 1005. doi:10.1001/archinte.1993.00410080065011. ISSN 0003-9926.
- ↑ Gupta M, Wadhwa NK, Bukovsky R (January 2004). “Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate”. Am. J. Kidney Dis. 43 (1): 67–73. PMID 14712429.
- ↑ Luke, R. G.; Galla, J. H. (2012). “It Is Chloride Depletion Alkalosis, Not Contraction Alkalosis”. Journal of the American Society of Nephrology. 23 (2): 204–207. doi:10.1681/ASN.2011070720. ISSN 1046-6673.
- ↑ Zaki, SyedAhmed; Lad, Vijay (2011). “Piperacillin-tazobactam-induced hypokalemia and metabolic alkalosis”. Indian Journal of Pharmacology. 43 (5): 609. doi:10.4103/0253-7613.84986. ISSN 0253-7613.
- ↑ Meltem, Akkas Camkurt; Figen, Coskun; Nalan, Metin Aksu; Mahir, Kunt; Sebnem, Bozkurt; Mehlika, Isildak; Kasim, Kilic Ahmet; Miyase, Bayraktar (2009). “A hypokalemic muscular weakness after licorice ingestion: a case report”. Cases Journal. 2 (1): 8053. doi:10.4076/1757-1626-2-8053. ISSN 1757-1626.
- ↑ Lin, Shih-Hua; Yang, Sung-Sen; Chau, Tom; Halperin, Mitchell L. (2003). “An Unusual Cause of Hypokalemic Paralysis: Chronic Licorice Ingestion”. The American Journal of the Medical Sciences. 325 (3): 153–156. doi:10.1097/00000441-200303000-00008. ISSN 0002-9629.
- ↑ Roerig, James L.; Steffen, Kristine J.; Mitchell, James E.; Zunker, Christie (2010). “Laxative Abuse”. Drugs. 70 (12): 1487–1503. doi:10.2165/11898640-000000000-00000. ISSN 0012-6667.
- ↑ Sahani, Mandeep M.; Brennan, John F.; Nwakanma, Chukwuemeka; Chow, May T.; Ing, Todd S.; Leehey, David J. (2001). “Metabolic Alkalosis in a Hemodialysis Patient After Ingestion of a Large Amount of an Antacid Medication”. Artificial Organs. 25 (4): 313–315. doi:10.1046/j.1525-1594.2001.06714.x. ISSN 0160-564X.
- ↑ Vanpee, Dominique; Delgrange, Etienne; Gillet, Jean-Bernard; Donckier, Julian (2000). “Ingestion of antacid tablets (Rennie®) and acute confusion”. The Journal of Emergency Medicine. 19 (2): 169–171. doi:10.1016/S0736-4679(00)00206-7. ISSN 0736-4679.
- ↑ Gan, Tong J.; Meyer, Tricia; Apfel, Christian C.; Chung, Frances; Davis, Peter J.; Eubanks, Steve; Kovac, Anthony; Philip, Beverly K.; Sessler, Daniel I.; Temo, James; Tram??r, Martin R.; Watcha, Mehernoor (2003). “Consensus Guidelines for Managing Postoperative Nausea and Vomiting”. Anesthesia & Analgesia: 62–71. doi:10.1213/01.ANE.0000068580.00245.95. ISSN 0003-2999.
- ↑ Gilbertson, Heather Ruth; Rogers, Elizabeth Jessie; Ukoumunne, Obioha Chukwunyere (2011). “Determination of a Practical pH Cutoff Level for Reliable Confirmation of Nasogastric Tube Placement”. Journal of Parenteral and Enteral Nutrition. 35 (4): 540–544. doi:10.1177/0148607110383285. ISSN 0148-6071.
- ↑ Hung, Patrick D.; Schubert, Mitchell L.; Mihas, Anastasios A. (2003). “Zollinger-Ellison syndrome”. Current Treatment Options in Gastroenterology. 6 (2): 163–170. doi:10.1007/s11938-003-0017-6. ISSN 1092-8472.
- ↑ Shapiro, Jennifer R.; Berkman, Nancy D.; Brownley, Kimberly A.; Sedway, Jan A.; Lohr, Kathleen N.; Bulik, Cynthia M. (2007). “Bulimia nervosa treatment: A systematic review of randomized controlled trials”. International Journal of Eating Disorders. 40 (4): 321–336. doi:10.1002/eat.20372. ISSN 0276-3478.
- ↑ Wedenoja, S.; HãGlund, P.; Holmberg, C. (2010). “Review article: the clinical management of congenital chloride diarrhoea”. Alimentary Pharmacology & Therapeutics. 31 (4): 477–485. doi:10.1111/j.1365-2036.2009.04197.x. ISSN 0269-2813. C1 control character in
|last2=at position 3 (help) - ↑ Bakal, Unal; Sarac, Mehmet; Aydin, Mustafa; Tartar, Tugay; Kazez, Ahmet (2016). “Recent changes in the features of hypertrophic pyloric stenosis”. Pediatrics International. 58 (5): 369–371. doi:10.1111/ped.12860. ISSN 1328-8067.
- ↑ Gennari, F. J.; Weise, W. J. (2008). “Acid-Base Disturbances in Gastrointestinal Disease”. Clinical Journal of the American Society of Nephrology. 3 (6): 1861–1868. doi:10.2215/CJN.02450508. ISSN 1555-9041.
- ↑ Kurzrock, Eric A.; Baskin, Laurence S.; Kogan, Barry A. (1998). “GASTROCYSTOPLASTY: LONG-TERM FOLLOWUP”. The Journal of Urology. 160 (6): 2182–2186. doi:10.1016/S0022-5347(01)62289-4. ISSN 0022-5347.
- ↑ Banga, Amit; Khilnani, G. C. (2009). “Post-hypercapnic Alkalosis is Associated with Ventilator Dependence and Increased ICU stay”. COPD: Journal of Chronic Obstructive Pulmonary Disease. 6 (6): 437–440. doi:10.3109/15412550903341448. ISSN 1541-2555.
- ↑ Elisaf M, Milionis H, Siamopoulos KC (1997). “Hypomagnesemic hypokalemia and hypocalcemia: clinical and laboratory characteristics”. Miner Electrolyte Metab. 23 (2): 105–12. PMID 9252977.
- ↑ Galla JH (February 2000). “Metabolic alkalosis”. J. Am. Soc. Nephrol. 11 (2): 369–75. PMID 10665945.
- ↑ Simon, David B.; Karet, Fiona E.; Hamdan, Jahed M.; Pietro, Antonio Di; Sanjad, Sami A.; Lifton, Richard P. (1996). “Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na–K–2CI cotransporter NKCC2”. Nature Genetics. 13 (2): 183–188. doi:10.1038/ng0696-183. ISSN 1061-4036.
- ↑ Fremont, Oliver T.; Chan, James C. M. (2012). “Understanding Bartter syndrome and Gitelman syndrome”. World Journal of Pediatrics. 8 (1): 25–30. doi:10.1007/s12519-012-0333-9. ISSN 1708-8569.
- ↑ Colussi G, Macaluso M, Brunati C, Minetti L (1994). “Calcium metabolism and calciotropic hormone levels in Gitelman’s syndrome”. Miner Electrolyte Metab. 20 (5): 294–301. PMID 7700218.
- ↑ Safian, Robert D.; Textor, Stephen C. (2001). “Renal-Artery Stenosis”. New England Journal of Medicine. 344 (6): 431–442. doi:10.1056/NEJM200102083440607. ISSN 0028-4793.
- ↑ Salih, Mahdi; Gautschi, Ivan; van Bemmelen, Miguel X.; Di Benedetto, Michael; Brooks, Alice S.; Lugtenberg, Dorien; Schild, Laurent; Hoorn, Ewout J. (2017). “A Missense Mutation in the Extracellular Domain ofαENaC Causes Liddle Syndrome”. Journal of the American Society of Nephrology. 28 (11): 3291–3299. doi:10.1681/ASN.2016111163. ISSN 1046-6673.
- ↑ Lasseigne, Brittany N.; Brooks, James D. (2018). “The Role of DNA Methylation in Renal Cell Carcinoma”. Molecular Diagnosis & Therapy. doi:10.1007/s40291-018-0337-9. ISSN 1177-1062.
- ↑ Araujo Castro, Marta; Marazuela Azpiroz, Mónica (2018). “Two types of ectopic Cushing syndrome or a continuum? Review”. Pituitary. doi:10.1007/s11102-018-0894-2. ISSN 1386-341X.
- ↑ Martell-Claros, Nieves; Abad-Cardiel, María; Alvarez-Alvarez, Beatriz; García-Donaire, José A.; Pérez, Cristina Fernández (2015). “Primary aldosteronism and its various clinical scenarios”. Journal of Hypertension. 33 (6): 1226–1232. doi:10.1097/HJH.0000000000000546. ISSN 0263-6352.
- ↑ Monticone S, Losano I, Tetti M, Buffolo F, Veglio F, Mulatero P (May 2018). “Diagnostic approach to low renin hypertension”. Clin. Endocrinol. (Oxf). doi:10.1111/cen.13741. PMID 29758100.
- ↑ Baş F, Toksoy G, Ergun-Longmire B, Uyguner ZO, Abalı ZY, Poyrazoğlu Ş, Karaman V, Avcı Ş, Altunoğlu U, Bundak R, Karaman B, Başaran S, Darendeliler F (April 2018). “Prevalence, clinical characteristics and long-term outcomes of classical 11 β-hydroxylase deficiency (11BOHD) in Turkish population and novel mutations in CYP11B1 gene”. J. Steroid Biochem. Mol. Biol. doi:10.1016/j.jsbmb.2018.04.001. PMID 29626607.
- ↑ Goldsmith, Oliver; Solomon, David H.; Horton, Richard (1967). “Hypogonadism and Mineralocorticoid Excess”. New England Journal of Medicine. 277 (13): 673–677. doi:10.1056/NEJM196709282771302. ISSN 0028-4793.
- ↑ Bates CM, Baum M, Quigley R (February 1997). “Cystic fibrosis presenting with hypokalemia and metabolic alkalosis in a previously healthy adolescent”. J. Am. Soc. Nephrol. 8 (2): 352–5. PMID 9048354.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Metabolic Alkalosis has the highest incidence and prevalence rate among the other acid base disorder in hospitalized patient. Limited data are found on its predilection to race, age, gender, region.
Epidemiology and Demographics
Incidence
- The incidence of metabolic alkalosis is highest among all other acid based disorders. The incidence of metabolic alkalosis is approximately 51% in hospitalized patient.[1]
Prevalence
- Metabolic Alkalosis is shown to occur in 70% of 13430 cases in a study.[2]
Case-fatality rate/Mortality rate
- The mortality rate with metabolic alkalosis is 45% with arterial blood pH 7.55 to 80% with arterial blood pH of 7.65. Treatment is usually supportive based on cause of the disease.
Age
- Patients of all age groups may develop Metabolic Alkalosis.
Race
- There is no racial predilection to Metabolic alkalosis.
Gender
- Metabolic Alkalosis affects men and women equally.
Region
- There is no regional predilection for Metabolic Alkalosis.
Developed Countries
- There is no sufficient data specifically mentioning population from developed countries.
Developing Countries
- There is no sufficient data specifically mentioning population from developing countries.
References
- ↑ “Alkalosis – StatPearls – NCBI Bookshelf”.
- ↑ Hodgkin JE, Soeprono FF, Chan DM (December 1980). “Incidence of metabolic alkalemia in hospitalized patients”. Crit Care Med. 8 (12): 725–8. doi:10.1097/00003246-198012000-00005. PMID 6778655.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]
Overview
Common risk factors in the development of Metabolic Alkalosis include Vomiting, Milk-alkali syndrome, Severe hypokalemia, Primary hyperaldosterinism, Cushing syndrome, Diuretics use and genetic disease for instances- Bartter and gitelman Disease.
Risk Factors
- Common risk factors in the development of Metabolic Alkalosis include Vomiting, Milk-alkali syndrome, Severe hypokalemia, Primary hyperaldosterinism, Cushing syndrome, Diuretics use and genetic disease for instances- Bartter and Gitelman Disease.
Common Risk Factors
- Common risk factors in the development of Metabolic Alkalosis in patients who have conditions include:
- Vomiting (most commonly seen in pyloric stenosis), NG suction
- Diuretics: Loop and thiazide diuretics.
- Diarrhea
- Cystic fibrosis.[1]
- Dietary potassium depletion.[2]
- Primary hyperaldosteronism: Conn syndrome or adenoma, hyperplasia, carcinoma, renin or glucocorticoid responsive.
- Secondary hyperaldosteronism: Reno vascular hypertension, edema (cirrhosis, heart failure, nephrotic syndrome), juxtaglomerular cell(renin producing) tumor, renal cell carcinoma, nephroblastoma
- Mineralocorticoid excess due to primary decorticosterone excess (11 beta, 17 alpha hydroxylase deficiency), licorice(glycyrrhetinic acid) Closing
</ref>missing for<ref>tag - Chloride deficient infant formula.
- Villous adenoma[3]
- congenital chloride diarrhea[4]
- Bartter and Gitelman syndrome. [5]
- liddle syndrome</ref> [6]
- hemangiopericytoma
- Gastrocystoplasty [7]
- Post hypercapneic metabolic alkalosis.
References
- ↑ Pedroli G, Liechti-Gallati S, Mauri S, Birrer P, Kraemer R, Foletti-Jäggi C, Bianchetti MG (1995). “Chronic metabolic alkalosis: not uncommon in young children with severe cystic fibrosis”. Am J Nephrol. 15 (3): 245–50. doi:10.1159/000168839. PMID 7618650.
- ↑ Sabatini S (March 1996). “The cellular basis of metabolic alkalosis”. Kidney Int. 49 (3): 906–17. doi:10.1038/ki.1996.125. PMID 8648937.
- ↑ Babior BM (October 1966). “Villous adenoma of the colon. Study of a patient with severe fluid and electrolyte disturbances”. Am J Med. 41 (4): 615–21. doi:10.1016/0002-9343(66)90223-3. PMID 5927076.
- ↑ Höglund P, Haila S, Socha J, Tomaszewski L, Saarialho-Kere U, Karjalainen-Lindsberg ML, Airola K, Holmberg C, de la Chapelle A, Kere J (November 1996). “Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea”. Nat Genet. 14 (3): 316–9. doi:10.1038/ng1196-316. PMID 8896562.
- ↑ Kurtz I (October 1998). “Molecular pathogenesis of Bartter’s and Gitelman’s syndromes”. Kidney Int. 54 (4): 1396–410. doi:10.1046/j.1523-1755.1998.00124.x. PMID 9767561.
- ↑ Warnock DG (January 1998). “Liddle syndrome: an autosomal dominant form of human hypertension”. Kidney Int. 53 (1): 18–24. doi:10.1046/j.1523-1755.1998.00728.x. PMID 9452995.
- ↑ Plawker MW, Rabinowitz SS, Etwaru DJ, Glassberg KI (August 1995). “Hypergastrinemia, dysuria-hematuria and metabolic alkalosis: complications associated with gastrocystoplasty”. J Urol. 154 (2 Pt 1): 546–9. doi:10.1097/00005392-199508000-00066. PMID 7609133.
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]
Overview
There is insufficient evidence to recommend routine screening for Metabolic alkalosis.
Screening
There is insufficient evidence to recommend routine screening for Metabolic alkalosis. But there are certain etiologies of metabolic alkalosis should be screened for early diagnosis.
References
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]
Overview
Common complications of Metabolic alkalosis include hypokalemia, hypomagnesaemia, hypophosphatemia, coronary arterial blood flow reduction, arrhythmia, anaerobic glycolysis, reduced ventilation leading to low arterial oxygen saturation, increased CO2, decreased blood flow to cerebral arteries leading to altered mental status, lethargy, tetany, delirium, seizure.
Natural History, Complications, and Prognosis
Natural History
- The mortality rate with metabolic alkalosis is 45% with arterial blood pH 7.55 to 80% with arterial blood pH of 7.65.
Complications
- Common complications of Metabolic alkalosis include:
- Electrolyte imbalances: hypokalemia, hypomagnesaemia, hypophosphatemia
- Coronary arterial blood flow reduction leading to angina, refractory arrhythmia
- Anaerobic glycolysis
- Reduced ventilation leading to low arterial oxygen saturation, increased CO2
- Decreased blood flow to cerebral arteries leading to altered mental status, lethargy, tetany, delirium, seizure. .
Prognosis
- Early stabilization of patient is associated with the most favorable prognosis.
References
Diagnosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Related Chapters
Related Chapters
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
